Akram Taherinasab
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
PU.1 inhibition sensitizes stem-monocytic AML to BCL2 blockade.
Journal: bioRxiv : the preprint server for biology
Published: February 06, 2026
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings.
Journal: Leukemia & lymphoma
Published: December 19, 2022
Blast morphology in the diagnostic work-up of Ph-like acute lymphoblastic leukemia.
Journal: Leukemia & lymphoma
Published: February 08, 2022
Systematic benchmarking of single-cell ATAC-sequencing protocols.
Journal: Nature biotechnology
Published: January 18, 2022
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors.
Journal: Leukemia
Published: December 04, 2021
Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemia.
Journal: Hematological oncology
Published: May 18, 2021
Ponatinib for the treatment of Ph-like acute lymphoblastic leukemia.
Journal: Leukemia & lymphoma
Published: November 05, 2020
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913.
Journal: Haematologica
Published: January 24, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026